Cost-effective reimbursement analysis for medical technologies in Europe
Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 20 EU countries
White Paper: Health Economic Evidence Requirements for Medical Devices in Europe
Get insights from MTRC White Papers to discover health economic evidence requirements and best practices for market access in the EU5
Recent news and posts
EU HTA Publication Digest: EU Joint Clinical Assessment: A Framework for Optimising Use with Cost-Effectiveness Decision-Making
MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest.
In a recent publication, Johns et al. examined the practical implications of the EU Joint Clinical Assessment (JCA) for countries considering cost-effectiveness analyses. The authors showed that while JCA harmonises the appraisal of clinical effectiveness and safety, its exclusion of economic evaluation leads to potential misalignment with national processes. They noted that economic analyses remain fragmented due to diverse national PICOs, a divergence that increases the complexity of evidence synthesis and could necessitate reliance on indirect comparisons. The study emphasized that earlier exchange of national PICOs could improve alignment, strengthen the usefulness of JCA outputs, and ultimately support more consistent patient access.
Access the full-text article here.